person · Reporting owner

Clark Celeste A.

Disclosed activity across 7 companies

Tapewire entity: 10967
SEC CIK: 0001261319

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
DARLING INGREDIENTS INC.DAR · Entity 3512	Director	May 07, 2026	May 08, 2026
HAIN CELESTIAL GROUP INCHAIN · Entity 7055	Director	October 30, 2025	November 03, 2025
Prestige Consumer Healthcare Inc.PBH · Entity 4350	Director	August 04, 2026	August 05, 2026
WELLS FARGO & COMPANY/MNWFC · Entity 2824	Director	April 01, 2026	April 02, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DARLING INGREDIENTS INC.

Report date May 07, 2026 · Filed May 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	20,567	Ending reported balance After 2026-05-07 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-05-07 · Grant · Acquired 2,650 · Balance 20,437 Row 2 · 2026-05-07 · Grant · Acquired 130 · Balance 20,567 F1: Deferred Stock Units (DSUs) granted in accordance with the 2026 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the prorated annual cash compensation increase the reporting person elected to receive in DSUs, divided by the closing market price of a share of the issuer's common stock on January 2, 2026. F2: These DSUs vest in full on December 31, 2026, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSUs will vest in a prorated portion based on the reporting person's time of service and the unvested DSUs will be forfeited.

Filing footnotes · ownership attribution and instrument terms

F1: Deferred Stock Units (DSUs) granted in accordance with the 2026 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the prorated annual cash compensation increase the reporting person elected to receive in DSUs, divided by the closing market price of a share of the issuer's common stock on January 2, 2026.

F2: These DSUs vest in full on December 31, 2026, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSUs will vest in a prorated portion based on the reporting person's time of service and the unvested DSUs will be forfeited.

HAIN CELESTIAL GROUP INC

Report date October 30, 2025 · Filed November 03, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	202,721	Reported balance After 2025-10-30 transaction · row 1 1 source row Row 1 · 2025-10-30 · Grant · Acquired 114,729 · Balance 202,721 F1: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
Common StockSEC Table I · non-derivative	IndirectBy Clesteen A. Clark Trust	83,000	Reported balance Holding disclosure · report date 2025-10-30 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 83,000

Filing footnotes · ownership attribution and instrument terms

F1: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

Prestige Consumer Healthcare Inc.

Report date August 04, 2026 · Filed August 05, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	Direct	16,511	Reported balance After 2026-08-04 transaction · row 1 1 source row Row 1 · 2026-08-04 · Grant · Acquired 2,981 · Balance 16,511 F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

WELLS FARGO & COMPANY/MN

Report date April 01, 2026 · Filed April 02, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible security	Direct	39,589.3131	Reported balance After 2026-04-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-04-01 · Grant · Acquired 341.3181 · Balance 39,589.3131 F1: Each Phantom Stock Unit represents the right to receive one share of Wells Fargo & Company common stock. F2: Deferred compensation shares payable in a lump sum or installments based upon director's election. F3: Includes dividend equivalents reinvested in additional Phantom Stock Units.
Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative	Direct	4,022	Reported balance Holding disclosure · report date 2026-04-01 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 4,022

Filing footnotes · ownership attribution and instrument terms

F1: Each Phantom Stock Unit represents the right to receive one share of Wells Fargo & Company common stock.

F2: Deferred compensation shares payable in a lump sum or installments based upon director's election.

F3: Includes dividend equivalents reinvested in additional Phantom Stock Units.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

AdvancePierre Foods Holdings, Inc.

Report date June 06, 2017 · Filed June 07, 2017

Section 16 reporting ended · disclosed 2017-06-07. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Ending reported balance After 2017-06-07 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2017-06-06 · Other · Disposed 8,211 · Balance 22,726 Row 2 · 2017-06-07 · Disposition to issuer · Disposed 22,726 · Balance 0 F1: Upon the closing of the merger (the "Merger") pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 25, 2017, by and among AdvancePierre Foods Holdings, Inc. (the "Issuer"), Tyson Foods, Inc. and DVB Merger Sub, Inc., each outstanding share of Issuer common stock ("Common Stock") was cancelled and converted into the right to receive a cash payment of $40.25 per share (the "Merger Consideration"), and each outstanding Issuer restricted stock unit was converted into the right to receive an amount of cash equal to the Merger Consideration.

Filing footnotes · ownership attribution and instrument terms

F1: Upon the closing of the merger (the "Merger") pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 25, 2017, by and among AdvancePierre Foods Holdings, Inc. (the "Issuer"), Tyson Foods, Inc. and DVB Merger Sub, Inc., each outstanding share of Issuer common stock ("Common Stock") was cancelled and converted into the right to receive a cash payment of $40.25 per share (the "Merger Consideration"), and each outstanding Issuer restricted stock unit was converted into the right to receive an amount of cash equal to the Merger Consideration.

Mead Johnson Nutrition Co

Report date June 15, 2017 · Filed June 15, 2017

Section 16 reporting ended · disclosed 2017-06-15. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2017-06-15 transaction · row 1 1 source row Row 1 · 2017-06-15 · Disposition to issuer · Disposed 12,661 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2017-06-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2017-06-15 · Disposition to issuer · Disposed 1,709 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.

F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock.

F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.

OMEGA PROTEIN CORP

Report date December 19, 2017 · Filed December 21, 2017

Section 16 reporting ended · disclosed 2017-12-21. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2017-12-19 transaction · row 1 1 source row Row 1 · 2017-12-19 · Disposition to issuer · Disposed 3,374 · Balance 0 F1: Includes shares of common stock (the "Common Stock") of Omega Protein Corporation (the "Company") held by the Reporting Person and awards of shares of restricted Common Stock previously granted, 3,374 shares of which vested immediately prior to the effective time of the Merger (as defined below). F2: On December 19, 2017, pursuant to the Agreement and Plan of Merger dated as of October 5, 2017 (the "Merger Agreement"), by and among the Company, Cooke Inc. ("Cooke") and Alpha MergerSub, Inc. ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger") with the Company continuing as the surviving entity and a wholly-owned indirect subsidiary of Cooke. Pursuant to the Merger Agreement, each share of Common Stock of the Company issued and outstanding immediately prior to the effective time of the merger was automatically cancelled and converted into the right to the receive $22.00 in cash, less any required tax withholdings.

Filing footnotes · ownership attribution and instrument terms

F1: Includes shares of common stock (the "Common Stock") of Omega Protein Corporation (the "Company") held by the Reporting Person and awards of shares of restricted Common Stock previously granted, 3,374 shares of which vested immediately prior to the effective time of the Merger (as defined below).

F2: On December 19, 2017, pursuant to the Agreement and Plan of Merger dated as of October 5, 2017 (the "Merger Agreement"), by and among the Company, Cooke Inc. ("Cooke") and Alpha MergerSub, Inc. ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger") with the Company continuing as the surviving entity and a wholly-owned indirect subsidiary of Cooke. Pursuant to the Merger Agreement, each share of Common Stock of the Company issued and outstanding immediately prior to the effective time of the merger was automatically cancelled and converted into the right to the receive $22.00 in cash, less any required tax withholdings.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 04, 2026 Filed Aug 5, 2026 20:07 UTC	Prestige Consumer Healthcare Inc. PBH · Entity 4350	GrantCommon Stock, par value $0.01 per share	2,981	$0.00	$0.00	Disclosure SEC source: 0001104659-26-091081 · tm2622318-2_4seq1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,511 F1 · shares: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document
May 07, 2026 Filed May 8, 2026 21:12 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	130	$37.64	$4,893.20	Disclosure SEC source: 0001193125-26-214986 · ownership.xml · nonDerivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,567 F1 · shares: Deferred Stock Units (DSUs) granted in accordance with the 2026 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the prorated annual cash compensation increase the reporting person elected to receive in DSUs, divided by the closing market price of a share of the issuer's common stock on January 2, 2026. F2 · acquired: These DSUs vest in full on December 31, 2026, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSUs will vest in a prorated portion based on the reporting person's time of service and the unvested DSUs will be forfeited. Read SEC document
May 07, 2026 Filed May 8, 2026 21:12 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	2,650	$0.00	$0.00	Disclosure SEC source: 0001193125-26-214986 · ownership.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,437 Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:36 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	341.3181	$80.57	$27,500.00	Disclosure SEC source: 0000072971-26-000208 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,589.3131 Underlying: Common Stock, $1 2/3 Par Value · 341.3181 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Stock Unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in a lump sum or installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in a lump sum or installments based upon director's election. F3 · balance_after: Includes dividend equivalents reinvested in additional Phantom Stock Units. Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:24 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	1,328	$37.64	$49,985.92	Disclosure SEC source: 0001193125-26-004535 · ownership.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,521 F1 · shares: Deferred Stock Units (DSU's) granted in accordance with the 2017 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the annual cash compensation the reporting person elected to receive in DSU's, divided by the closing market price of a share of the issuer's common stock on January 2, 2026. F2 · acquired: These DSUs vest in full on December 31, 2026, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSU's will vest in a prorated portion based on the reporting person's time of service and the unvested DSU's will be forfeited. Read SEC document
January 02, 2026 Filed Feb 17, 2026 21:19 UTC Amendment	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	1,594	$37.64	$59,998.16	Disclosure SEC source: 0001193125-26-054717 · ownership.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,787 F1 · shares: Deferred Stock Units (DSU's) granted in accordance with the 2017 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the annual cash compensation the reporting person elected to receive in DSU's, divided by the closing market price of a share of the issuer's common stock on January 2, 2026. F2 · shares: This amendment corrects the number of DSUs acquired, which was inadvertently underreported due to an administrative error. F3 · acquired: These DSUs vest in full on December 31, 2026, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSU's will vest in a prorated portion based on the reporting person's time of service and the unvested DSU's will be forfeited. Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:03 UTC	HAIN CELESTIAL GROUP INC HAIN · Entity 7055	GrantCommon Stock	114,729	$0.00	$0.00	Disclosure SEC source: 0001193125-25-262517 · ownership.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,721 F1 · shares: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. Read SEC document
August 05, 2025 Filed Aug 6, 2025 20:02 UTC	Prestige Consumer Healthcare Inc. PBH · Entity 4350	GrantCommon Stock, par value $0.01 per share	2,094	$0.00	$0.00	Disclosure SEC source: 0001104659-25-074697 · tm2522759-2_4seq1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,530 F1 · shares: The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $74.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document
May 13, 2025 Filed May 15, 2025 21:46 UTC	HAIN CELESTIAL GROUP INC HAIN · Entity 7055	PurchaseCommon Stock	83,000	$1.79	$148,960.10	Disclosure SEC source: 0000950170-25-072902 · ownership.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Clesteen A. Clark Trust Disclosed balance after: 83,000 Read SEC document
May 07, 2025 Filed May 8, 2025 21:31 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	4,549	$0.00	$0.00	Disclosure SEC source: 0000950170-25-067245 · ownership.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,193 Read SEC document
April 29, 2025 Filed May 1, 2025 21:26 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantCommon Stock Units · Derivative	3,728	$71.10	$265,060.80	Disclosure SEC source: 0001127602-25-012987 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,108.4723 Underlying: Common Stock, $1 2/3 Par Value · 3,728 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F3 · balance_after: Includes dividend equivalents reinvested in additional Common Stock Units. Read SEC document
October 31, 2024 Filed Nov 4, 2024 21:06 UTC	HAIN CELESTIAL GROUP INC HAIN · Entity 7055	GrantCommon Stock	19,474	$0.00	$0.00	Disclosure SEC source: 0000950170-24-120681 · ownership.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,992 F1 · shares: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 31, 2025 or the date of the Issuer's 2025 annual meeting of shareholders. Read SEC document
August 06, 2024 Filed Aug 7, 2024 20:04 UTC	Prestige Consumer Healthcare Inc. PBH · Entity 4350	GrantCommon Stock, par value $0.01 per share	2,202	$0.00	$0.00	Disclosure SEC source: 0001104659-24-086747 · tm2421115-4_4seq1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,436 F1 · shares: The Reporting Person received 2,202 restricted stock units equal to $150,000 divided by the closing stock price of $68.13 on August 6, 2024, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document
May 07, 2024 Filed May 9, 2024 20:25 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	3,369	$0.00	$0.00	Disclosure SEC source: 0000950170-24-057055 · ownership.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,644 Read SEC document
April 30, 2024 Filed May 2, 2024 20:25 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantCommon Stock Units · Derivative	4,046	$59.32	$240,008.72	Disclosure SEC source: 0001127602-24-013987 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,106.1884 Underlying: Common Stock, $1 2/3 Par Value · 4,046 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:01 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	476.1784	$49.22	$23,437.50	Disclosure SEC source: 0001127602-24-000532 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,301.3364 Underlying: Common Stock, $1 2/3 Par Value · 476.1784 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
October 26, 2023 Filed Oct 30, 2023 20:49 UTC	HAIN CELESTIAL GROUP INC HAIN · Entity 7055	GrantCommon Stock	15,098	$0.00	$0.00	Disclosure SEC source: 0000910406-23-000101 · wk-form4_1698698982.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,518 F1 · shares: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 26, 2024 or the date of the Issuer's 2024 annual meeting of shareholders. Read SEC document
October 01, 2023 Filed Oct 3, 2023 21:14 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	573.605	$40.86	$23,437.50	Disclosure SEC source: 0001127602-23-025304 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,541.0762 Underlying: Common Stock, $1 2/3 Par Value · 573.605 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
August 01, 2023 Filed Aug 3, 2023 18:01 UTC	Prestige Consumer Healthcare Inc. PBH · Entity 4350	GrantCommon Stock, par value $0.01 per share	2,295	$0.00	$0.00	Disclosure SEC source: 0001104659-23-087188 · tm2322776-2_4seq1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,234 F1 · shares: The Reporting Person received 2,295 restricted stock units equal to $150,000 divided by the closing stock price of $65.37 on August 1, 2023, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document
July 01, 2023 Filed Jul 5, 2023 21:04 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	549.1448	$42.68	$23,437.50	Disclosure SEC source: 0001127602-23-020163 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,667.7425 Underlying: Common Stock, $1 2/3 Par Value · 549.1448 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
May 09, 2023 Filed May 11, 2023 20:30 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	53	$61.01	$3,233.53	Disclosure SEC source: 0001140361-23-024168 · form4.xml · nonDerivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,275 F1 · shares: Deferred Stock Units (DSUs) granted in accordance with the 2017 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the prorated annual cash compensation increase the reporting person elected to receive in DSUs, divided by the closing market price of a share of the issuer's common stock on January 3, 2023. F2 · shares: These DSUs vest in full on December 31, 2023, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSUs will vest in a prorated portion based on the reporting person's time of service and the unvested DSUs will be forfeited. Read SEC document
May 09, 2023 Filed May 11, 2023 20:30 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	2,571	$0.00	$0.00	Disclosure SEC source: 0001140361-23-024168 · form4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,222 Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:15 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantCommon Stock Units · Derivative	5,919	$40.55	$240,015.45	Disclosure SEC source: 0001127602-23-013667 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,919 Underlying: Common Stock, $1 2/3 Par Value · 5,919 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. Read SEC document
April 01, 2023 Filed Apr 4, 2023 16:01 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	627.0064	$37.38	$23,437.50	Disclosure SEC source: 0001127602-23-012055 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,857.5575 Underlying: Common Stock, $1 2/3 Par Value · 627.0064 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
January 03, 2023 Filed Jan 4, 2023 21:30 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	1,557	$61.01	$94,992.57	Disclosure SEC source: 0001567619-23-000242 · doc1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 F1 · shares: Deferred Stock Units (DSUs) granted in accordance with the 2017 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the annual cash compensation the reporting person elected to receive in DSUs, divided by the closing market price of a share of the issuer's common stock on January 3, 2023. F2 · acquired: These DSUs vest in full on December 31, 2023, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSUs will vest in a prorated portion based on the reporting person's time of service and the unvested DSUs will be forfeited. Read SEC document
January 01, 2023 Filed Jan 4, 2023 17:02 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	567.6314	$41.29	$23,437.50	Disclosure SEC source: 0001127602-23-000292 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,011.9647 Underlying: Common Stock, $1 2/3 Par Value · 567.6314 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
November 17, 2022 Filed Nov 21, 2022 21:23 UTC	HAIN CELESTIAL GROUP INC HAIN · Entity 7055	GrantCommon Stock	11,930	$0.00	$0.00	Disclosure SEC source: 0000910406-22-000085 · wf-form4_166906577413024.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,420 F1 · shares: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of November 17, 2023 or the date of the Issuer's 2023 annual meeting of stockholders. Read SEC document
October 01, 2022 Filed Oct 4, 2022 15:35 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	582.7325	$40.22	$23,437.50	Disclosure SEC source: 0001127602-22-023371 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,231.6282 Underlying: Common Stock, $1 2/3 Par Value · 582.7325 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
August 02, 2022 Filed Aug 3, 2022 21:17 UTC	Prestige Consumer Healthcare Inc. PBH · Entity 4350	GrantCommon Stock, par value $0.01 per share	2,495	$0.00	$0.00	Disclosure SEC source: 0001104659-22-085706 · tm2222537-2_4seq1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,939 F1 · shares: The Reporting Person received 2,495 restricted stock units (equal to $150,000 divided by the closing stock price of $60.12 on August 2, 2022) in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document
July 01, 2022 Filed Jul 6, 2022 15:56 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	587.1117	$39.92	$23,437.50	Disclosure SEC source: 0001127602-22-018886 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,426.2896 Underlying: Common Stock, $1 2/3 Par Value · 587.1117 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
May 10, 2022 Filed May 11, 2022 20:36 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	1,817	$0.00	$0.00	Disclosure SEC source: 0001567619-22-010073 · doc1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,094 Read SEC document
April 26, 2022 Filed Apr 28, 2022 16:44 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	5,384	$44.58	$240,018.72	Disclosure SEC source: 0001127602-22-012631 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,663.891 Underlying: Common Stock, $1 2/3 Par Value · 5,384 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
April 01, 2022 Filed Apr 1, 2022 23:48 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	631.2872	$48.71	$30,750.00	Disclosure SEC source: 0001127602-22-010963 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,279.891 Underlying: Common Stock, $1 2/3 Par Value · 631.2872 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:48 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	1,360	$69.84	$94,982.40	Disclosure SEC source: 0001567619-22-000571 · doc1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,277 F1 · shares: Deferred Stock Units (DSUs) granted in accordance with the 2017 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of annual cash compensation the reporting person elected to receive in DSUs, divided by the closing market price of a share of the issuer's common stock on January 3, 2022 F2 · acquired: These DSUs vest in full on December 31, 2022, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSUs will vest in a prorated portion based on the reporting person's time of service and the unvested DSUs will be forfeited. Read SEC document
January 01, 2022 Filed Jan 4, 2022 17:19 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	130.2626	$47.98	$6,250.00	Disclosure SEC source: 0001127602-22-000287 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,521.7308 Underlying: Common Stock, $1 2/3 Par Value · 130.2626 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
October 28, 2021 Filed Nov 1, 2021 20:04 UTC	HAIN CELESTIAL GROUP INC HAIN · Entity 7055	GrantCommon Stock	5,187	$0.00	$0.00	Disclosure SEC source: 0000910406-21-000047 · wf-form4_163579706640166.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,490 F1 · shares: Represents a grant of restricted stock units as compensation under the Issuer's compensation program for non-employee directors. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The restricted stock units will vest on the earlier of October 28, 2022 or the date of the Issuer's 2022 annual meeting of stockholders. Read SEC document
October 26, 2021 Filed Oct 27, 2021 20:18 UTC	DARLING INGREDIENTS INC. DAR · Entity 3512	GrantCommon Stock	917	$0.00	$0.00	Disclosure SEC source: 0001567619-21-018790 · doc1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 917 Read SEC document
October 01, 2021 Filed Oct 5, 2021 16:11 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	132.9222	$47.02	$6,250.00	Disclosure SEC source: 0001127602-21-026625 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,284.354 Underlying: Common Stock, $1 2/3 Par Value · 132.9222 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
August 03, 2021 Filed Aug 5, 2021 23:01 UTC	Prestige Consumer Healthcare Inc. PBH · Entity 4350	GrantCommon Stock, par value $0.01 per share	2,808	$0.00	$0.00	Disclosure SEC source: 0001104659-21-100933 · tm2124298-3_4seq1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,444 F1 · shares: The Reporting Person received 2,808 restricted stock units (equal to $150,000 divided by the closing stock price of $53.42 on August 3, 2021) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document
July 01, 2021 Filed Jul 2, 2021 21:24 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	137.6349	$45.41	$6,250.00	Disclosure SEC source: 0001127602-21-021325 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,036.1904 Underlying: Common Stock, $1 2/3 Par Value · 137.6349 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
May 03, 2021 Filed May 5, 2021 20:27 UTC	Prestige Consumer Healthcare Inc. PBH · Entity 4350	GrantCommon Stock, par value $0.01 per share	1,636	$0.00	$0.00	Disclosure SEC source: 0001104659-21-061747 · tm2115301-2_4seq1.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,636 F1 · shares: The Reporting Person received 1,636 restricted stock units (equal to $72,500 divided by the closing stock price of $44.33 on May 3, 2021). The restricted stock units vest on May 4, 2022. Read SEC document
April 27, 2021 Filed Apr 29, 2021 17:24 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	3,993	$45.09	$180,044.37	Disclosure SEC source: 0001127602-21-014635 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,845.9827 Underlying: Common Stock, $1 2/3 Par Value · 3,993 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
April 01, 2021 Filed Apr 5, 2021 18:58 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	157.7088	$39.63	$6,250.00	Disclosure SEC source: 0001127602-21-013002 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,852.9827 Underlying: Common Stock, $1 2/3 Par Value · 157.7088 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
January 01, 2021 Filed Jan 5, 2021 22:02 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	1,018.8867	$30.18	$30,750.00	Disclosure SEC source: 0001127602-21-000681 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,639.6266 Underlying: Common Stock, $1 2/3 Par Value · 1,018.8867 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
November 24, 2020 Filed Nov 25, 2020 21:05 UTC	HAIN CELESTIAL GROUP INC HAIN · Entity 7055	GrantCommon Stock	6,232	$0.00	$0.00	Disclosure SEC source: 0000910406-20-000075 · wf-form4_160633833789724.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,303 F1 · shares: Represents a grant of restricted stock units as compensation under the Issuer's compensation program for non-employee directors. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The restricted stock units will vest on the earlier of November 24, 2021 or the date of the Issuer's 2021 annual meeting of stockholders. Read SEC document
October 01, 2020 Filed Oct 2, 2020 21:33 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	1,644.7368	$23.56	$38,750.00	Disclosure SEC source: 0001127602-20-026363 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,551.0642 Underlying: Common Stock, $1 2/3 Par Value · 1,644.7368 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
July 01, 2020 Filed Jul 6, 2020 14:04 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	1,544.44	$25.09	$38,750.00	Disclosure SEC source: 0001127602-20-021072 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,832.181 Underlying: Common Stock, $1 2/3 Par Value · 1,544.44 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
April 28, 2020 Filed Apr 30, 2020 17:25 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	6,235	$28.87	$180,004.45	Disclosure SEC source: 0001127602-20-014724 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,986.772 Underlying: Common Stock, $1 2/3 Par Value · 6,235 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
April 01, 2020 Filed Apr 3, 2020 16:30 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	1,684.2303	$26.57	$44,750.00	Disclosure SEC source: 0001127602-20-012958 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,751.772 Underlying: Common Stock, $1 2/3 Par Value · 1,684.2303 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document
January 01, 2020 Filed Jan 3, 2020 18:02 UTC	WELLS FARGO & COMPANY/MN WFC · Entity 2824	GrantPhantom Stock Units · Derivative	608.7361	$53.80	$32,750.00	Disclosure SEC source: 0001127602-20-000423 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,968.0629 Underlying: Common Stock, $1 2/3 Par Value · 608.7361 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.